Cognitive impairment in Parkinson disease correlates with loss of cholinergic axon projections to cortex in an autopsy study
Alzheimer's & Dementia · 2026-10 · 22 (10)
DOI: 10.1002/alz.71868 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 06.10.2026. Verfasst von Rebecca Miller und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Axons, Cholinergic Neurons, Cognitive Dysfunction. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, American Parkinson Disease Association.
Abstract (Originalsprache)
INTRODUCTION People with Parkinson's disease (PD) frequently develop dementia. We investigated the relationship between cognitive impairment and the loss of cholinergic axon projections from the nucleus basalis of Meynert to neocortical regions in PD. METHODS Levels of choline acetyltransferase (ChAT), the enzyme required for acetylcholine synthesis, were measured with a sandwich enzyme‐linked immunosorbent assay (ELISA) in eight brain regions from 37 PD autopsy cases. Analyses focused on relationships between measures of global cognitive impairment and average ChAT levels in four neocortical regions. RESULTS Mean neocortical ChAT levels positively correlated with the Mini‐Mental State Examination and a global cognition z‐score obtained by averaging performance in multiple cognitive domains. Mean neocortical ChAT levels also showed a trending inverse correlation with the Clinical Dementia Rating sum of boxes. DISCUSSION These results indicate a role for the loss of cholinergic projections to neocortical regions in the development of cognitive impairment in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.
- Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, USA.
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
- Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, USA.
- Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.
- Department of Neuroscience, Washington University School of Medicine, St. Louis, Missouri, USA.
ORCID-Profile: Paul Kotzbauer
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- American Parkinson Disease Association
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Miller, R., O'Shea, J., Rosok, L. M., Lim, S., Franklin, E. E., Perrin, R. J., Hwang, H., Dhavale, D., Perlmutter, J., Campbell, M. C., & Kotzbauer, P. (2026). Cognitive impairment in Parkinson disease correlates with loss of cholinergic axon projections to cortex in an autopsy study. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71868
Vancouver
Miller R, O'Shea J, Rosok LM, Lim S, Franklin EE, Perrin RJ, et al. Cognitive impairment in Parkinson disease correlates with loss of cholinergic axon projections to cortex in an autopsy study. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71868
BibTeX
@article{Miller2026,
author = {Miller, Rebecca and O'Shea, Jennifer and Rosok, Laura M and Lim, Sydney and Franklin, Erin E and Perrin, Richard J and Hwang, Helen and Dhavale, Dhruva and Perlmutter, Joel and Campbell, Meghan C and Kotzbauer, Paul},
title = {Cognitive impairment in Parkinson disease correlates with loss of cholinergic axon projections to cortex in an autopsy study},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {10},
doi = {10.1002/alz.71868}
}
EUVIMED